Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

PeerVoice - Extending overall survival in nmCRPC while maintaining quality of life: Can we have it all?

Mitigating and managing adverse events associated with androgen receptor-targeted therapies

Date

14 Sep 2020

Session

PeerVoice - Extending overall survival in nmCRPC while maintaining quality of life: Can we have it all?

Presenters

Jennifer Sutton

Authors

N. Shore1, K. Fizazi2, G. Kramer3, J. Sutton4

Author affiliations

  • 1 Urology, Atlantic Urology Clinics, 29572 - Myrtle Beach/US
  • 2 Cancer Medicine Department, Institut Gustave Roussy, 94805 - Villejuif/FR
  • 3 N/a, Medical University of Vienna, n/a - Vienna/AT
  • 4 Carolina Urologic Research Center, Myrtle Beach/US
More

Resources

Login to access the resources on OncologyPRO.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings